Understanding how binge drinking affects blood pressure in middle-aged adults
Reducing blood pressure in mid-life adult binge drinkers: the role of microvascular function and sympathetic activity
This study is looking at how binge drinking affects blood pressure in adults aged 50 to 64, and it aims to find ways to help prevent and treat high blood pressure caused by drinking too much.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-10830399 on NIH RePORTER |
What this research studies
This research investigates the relationship between binge drinking and high blood pressure in mid-life adults aged 50-64. It aims to uncover the mechanisms that lead to elevated blood pressure, focusing on how binge drinking impacts microvascular function and sympathetic nerve activity. The study will utilize a combination of vascular physiology assessments and physical therapies to develop preventative and therapeutic strategies for alcohol-induced hypertension. By addressing these issues, the research seeks to fill a significant gap in knowledge regarding this under-studied age group.
Who could benefit from this research
Good fit: Ideal candidates for this research are mid-life adults aged 50-64 who engage in binge drinking and may have elevated blood pressure.
Not a fit: Patients who do not binge drink or are outside the age range of 50-64 may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing blood pressure in middle-aged adults who engage in binge drinking.
How similar studies have performed: Previous research has shown that binge drinking can negatively affect vascular function, suggesting that this approach may yield valuable insights.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Hwang, Chueh-Lung — University of Texas Arlington
- Study coordinator: Hwang, Chueh-Lung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.